FindTrial
Sign In

Sevoflurane on cardiac surgery: vantage to use during CEC

Sevoflurane on cardiac surgery: vantage to use during CEC

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-001574-27-IT
Enrollment
Unknown
Registered
2007-07-09
Start date
2005-09-27
Completion date
Unknown
Last updated
2014-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anestetic inalathory also during CEC MedDRA version: 6.1 Level: PT Classification code 10018060

Interventions

Trade Name: SEVORANE*INAL 250ML QUIK FIL Pharmaceutical Form: Inhalation gas INN or Proposed INN: Sevoflurane CAS Number: 28523-86-6 Concentration unit: mg milligram(s) Concentration type: equal

Sponsors

AZIENDA OSPEDALIERA DI PERUGIA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026